{"schemaVersion":"2.1","datasetVersion":"2026-07-24.2","generatedAt":"2026-07-24","reviewStatus":"Editorial source review completed; not independently medically reviewed","editorialBoundary":"Educational evidence summaries only. No dosing, sourcing, reconstitution, injection, cycling, stacking, or self-treatment instructions.","citation":"Cite The Peptide Field, the record canonicalPath, dataset version 2026-07-24.2, and every underlying source used for the claim.","reuse":"No additional reuse license is granted by this endpoint. Preserve verdict, scope, evidence basis, review date, and source links together; do not present a record as medical advice or medical review.","changeLogPath":"/corrections#correction-ledger","contactPath":"/corrections","dataset":"glossary","count":37,"records":[{"term":"Active ingredient","definition":"The component intended to produce a drug's effect. An ingredient name is not a complete product identity.","relatedGuide":"/learn/molecule-vs-product"},{"term":"Adverse event","definition":"An unfavorable medical occurrence after exposure. It is not automatically caused by the intervention, but it must be recorded and evaluated."},{"term":"Agonist","definition":"A molecule that activates a receptor. Receptor activation establishes a mechanism, not necessarily a useful patient outcome."},{"term":"Alias","definition":"Another name used for a molecule or product. Aliases can hide important differences in sequence, salt form, modification, or formulation."},{"term":"Approved indication","definition":"A specific use, population, and condition reviewed by a regulator for a particular drug product.","relatedGuide":"/learn/approved-vs-compounded"},{"term":"Biomarker","definition":"A measured biological signal such as a hormone level. A biomarker can support biological activity without proving that patients feel or function better.","relatedGuide":"/learn/animal-vs-human"},{"term":"Blinding","definition":"A study method that limits knowledge of treatment assignment to reduce expectation and measurement bias."},{"term":"Clinical outcome","definition":"An outcome that reflects how a person feels, functions, survives, or uses healthcare, rather than only a laboratory change."},{"term":"Compounded drug","definition":"A drug prepared for an identified patient or under other compounding provisions. Compounded drugs are not FDA-approved and are not premarket-reviewed for safety, effectiveness, or quality.","relatedGuide":"/learn/approved-vs-compounded"},{"term":"Comparator","definition":"The group or intervention against which a treatment is tested, such as placebo, usual care, or another active drug."},{"term":"Confidence interval","definition":"A range that expresses statistical uncertainty around an estimate. Narrower intervals usually indicate greater precision."},{"term":"Endpoint","definition":"A prespecified measurement used to judge a study result. Primary, secondary, and exploratory endpoints carry different evidentiary weight."},{"term":"Evidence transfer","definition":"Applying a result from one molecule, product, route, population, or endpoint to another. Transfer requires evidence, not just similarity.","relatedGuide":"/learn/molecule-vs-product"},{"term":"Formulation","definition":"The complete drug preparation, including active ingredient, concentration, excipients, route, and physical form."},{"term":"Human pharmacology","definition":"Evidence that a substance changes exposure, receptor activity, hormones, or other biological measures in people. It does not by itself establish clinical benefit."},{"term":"Immunogenicity","definition":"The potential for a substance or impurity to trigger an immune response. Peptide aggregation, modifications, impurities, route, and storage can affect risk."},{"term":"Investigational","definition":"Being studied for possible use. Investigational does not mean approved, proven, or available for routine self-treatment."},{"term":"Mechanism","definition":"A proposed or demonstrated biological process. Mechanistic plausibility is an early rung on the evidence ladder."},{"term":"Observational study","definition":"A study that observes exposure and outcomes without random assignment. It can reveal associations but is more vulnerable to confounding."},{"term":"Peptide","definition":"A chain of amino acids. The category includes natural signals, approved medicines, research molecules, and unverified products.","relatedGuide":"/learn/what-are-peptides"},{"term":"Pharmacodynamics","definition":"What a substance does to the body, including receptor activity, hormone release, or other measured responses."},{"term":"Pharmacokinetics","definition":"How the body absorbs, distributes, metabolizes, and eliminates a substance over time."},{"term":"Placebo","definition":"An inactive or comparison intervention used to estimate effects beyond expectation, natural history, and study participation."},{"term":"Preclinical","definition":"Research conducted before or outside human clinical testing, commonly in cells, tissues, or animals.","relatedGuide":"/learn/animal-vs-human"},{"term":"Primary source","definition":"The original regulatory record, trial report, registry result, or study publication rather than a summary or promotional retelling.","relatedGuide":"/learn/verify-a-peptide-claim"},{"term":"Product certainty","definition":"Confidence that the material being discussed has known identity, quality, formulation, route, storage, and manufacturing controls."},{"term":"Randomization","definition":"Assigning participants to study groups by chance to reduce systematic differences and confounding."},{"term":"Registration","definition":"A public study plan. Registration improves transparency but is not proof that a trial was completed or produced a positive result."},{"term":"RETA (retatrutide)","definition":"RETA is informal online shorthand for retatrutide (LY3437943), an investigational single molecule that activates GIP, GLP-1, and glucagon receptors. The nickname is not an approved product name and cannot establish the identity, purity, or quality of material sold online.","alsoKnownAs":["RETA","Retatrutide","LY3437943","triple-receptor agonist","triple G agonist"],"detailPath":"/glossary/reta"},{"term":"Route of administration","definition":"How a product enters the body, such as oral, topical, subcutaneous, or intravenous. Evidence and risk can change materially by route."},{"term":"Salt form","definition":"A chemical form used to affect stability or handling. Free base and acetate forms should not be treated as identical without supporting characterization."},{"term":"Scope","definition":"The population, product, route, endpoint, comparator, and duration to which a conclusion applies."},{"term":"Sequence","definition":"The ordered amino-acid chain of a peptide. A fragment, modification, or extra chemical group can create a different evidence object."},{"term":"Statistical significance","definition":"Evidence that a result is unlikely under a specified null model. It does not establish that the effect is large, important, unbiased, or reproducible."},{"term":"Systematic review","definition":"A structured effort to find, appraise, and synthesize all eligible studies for a defined question."},{"term":"Trial registry","definition":"A public record of a study's planned methods and status. Results must still be checked separately."},{"term":"UNII","definition":"A Unique Ingredient Identifier used by FDA's substance-registration system. A UNII identifies a substance and does not imply approval."}]}